ERBB2 and neoplasm: Using the highest MTVcsc in the pCR group as a cutoff (<1.75 cm3), MTVcsc provided the opportunity to predict the pathologic tumor response to NAC with an accuracy of 74% (61/82) in HER2-positive and TN subtypes (Table 3).